Skip to main content

Schonfeld Strategic Advisors LLC

Position in DXCM — Dexcom Inc

CIK 1665241 NEW YORK, NY

Position in DXCM

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,604,004
-$16,310,759 QoQ
Shares Held
152,930
-60.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Dec 31, 2023
CallValue
$1,861,350
CallShares
15,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $205,253,916 across 27 Medical Devices names. DXCM ranks #6 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 DXCM
Dexcom Inc
This page
152,930 $9,604,004

All Filings in DXCM

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,604,004 152,930
2025-12-31 $25,914,763 390,459
2025-09-30 $24,540,663 364,700
2025-06-30 $3,023,027 34,632
2025-03-31 $1,283,783 18,799
2024-12-31 $11,454,898 147,292
2024-09-30 $762,378 11,372
2024-06-30 $7,363,577 64,946
2024-03-31 $8,189,125 59,042
2023-12-31 $1,861,350 15,000
2023-12-31 $9,788,591 78,883
2023-09-30 $28,330,265 303,647
2023-06-30 $9,792,719 76,202
2023-03-31 $10,635,117 91,540
2022-12-31 $6,658,625 58,801
2022-09-30 $1,465,828 18,200
2022-06-30 $4,774,391 64,060
2022-03-31 $1,270,174 9,931
2021-12-31 $2,723,141 20,286
2021-09-30 $1,701,828 12,448
2021-06-30 $529,693 4,962
2021-03-31 $188,679 2,100
2020-12-31 $1,127,646 12,200
2020-09-30 $133,974 1,300
2020-06-30 $1,209,510 11,934
2020-03-31 $343,319 5,100